TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve 1) To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended September 30, 2023. 2. To consider and approve the appointment of M/s.Vasavi & Co, chartered Accountants as Statutory Auditors of the Company for a period of Five years from the financial year 2023-24 upto-2027-2028, subject to the approval of members in the ensuing annual general meeting. 3. To consider and approve the appointment of M/s.Manisha Dubey, as internal auditor of the Company for financial year 2023-24. 4. To consider and approve the Notice of the 33 rd Annual General meeting for the Financial Year 2022-2023 and other related matters thereto. 5. To consider and approve Directors' Report and the annexure thereon for the Financial Year 2022-2023. 6. To transact such other business as may be required.